Arcutis Biotherapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 08/14/2026 | 12.44 M | $326.10 M | 0.89% | 9.61% |
| BLACKROCK, INC. | 08/07/2026 | 10.55 M | $276.50 M | 14.62% | 8.15% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/14/2026 | 9.87 M | $258.91 M | 0.00% | 7.63% |
| RUBRIC CAPITAL MANAGEMENT LP | 08/14/2026 | 8.27 M | $216.88 M | 0.00% | 6.39% |
| POLAR CAPITAL HOLDINGS PLC | 08/14/2026 | 6.61 M | $173.23 M | 16.59% | 5.11% |
| STATE STREET CORP | 08/07/2026 | 5.82 M | $152.67 M | -7.52% | 4.50% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 4.99 M | $130.81 M | 2.41% | 3.86% |
| MORGAN STANLEY | 08/13/2026 | 4.45 M | $116.71 M | 5.50% | 3.44% |
| JENNISON ASSOCIATES LLC | 08/03/2026 | 4.22 M | $110.62 M | -15.29% | 3.26% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 3.95 M | $103.56 M | 58.22% | 3.05% |
| UBS GROUP AG | 08/13/2026 | 3.33 M | $87.39 M | 0.11% | 2.58% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 2.99 M | $78.33 M | 34.49% | 2.31% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 2.98 M | $78.21 M | -2.06% | 2.31% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 2.43 M | $63.69 M | 24.27% | 1.88% |
| ORBIMED ADVISORS LLC | 08/14/2026 | 2.04 M | $53.54 M | 100.00% | 1.58% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 1.93 M | $50.63 M | -15.97% | 1.49% |
| AMERICAN CENTURY COMPANIES INC | 08/12/2026 | 1.93 M | $50.47 M | 31.56% | 1.49% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 1.67 M | $43.74 M | 4.08% | 1.29% |
| JUPITER TOPCO LLC | 08/14/2026 | 1.41 M | $36.99 M | 100.00% | 1.09% |
| OBERWEIS ASSET MANAGEMENT INC/ | 08/14/2026 | 1.37 M | $36.00 M | 0.51% | 1.06% |
| GILDER GAGNON HOWE & CO LLC | 08/14/2026 | 1.31 M | $34.43 M | -69.49% | 1.02% |
| GW&K INVESTMENT MANAGEMENT, LLC | 08/12/2026 | 1.29 M | $33.77 M | 30.32% | 1.00% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 08/13/2026 | 1.27 M | $33.18 M | -6.68% | 0.98% |
| BAMCO INC /NY/ | 08/14/2026 | 1.25 M | $32.86 M | 16.87% | 0.97% |
| CITADEL ADVISORS LLC | 08/14/2026 | 1.16 M | $30.42 M | 7,333.13% | 0.90% |
| FEDERATED HERMES, INC. | 08/12/2026 | 1.12 M | $29.49 M | 4.40% | 0.87% |
| PERPETUAL LTD | 07/15/2026 | 1.11 M | $29.10 M | 22.00% | 0.86% |
| ABRDN PLC | 07/31/2026 | 1.10 M | $28.80 M | 70.28% | 0.85% |
| JONES HILL CAPITAL LP | 08/13/2026 | 1.09 M | $28.57 M | 100.00% | 0.84% |
| NORTHERN TRUST CORP | 08/13/2026 | 1.06 M | $27.76 M | 8.40% | 0.82% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 1.05 M | $27.56 M | 3.79% | 0.81% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 1.05 M | $27.56 M | 100.00% | 0.81% |
| ENSIGN PEAK ADVISORS, INC | 08/14/2026 | 974.53 K | $25.55 M | -21.69% | 0.75% |
| CANDRIAM S.C.A. | 08/13/2026 | 949.84 K | $24.88 M | -12.59% | 0.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 08/14/2026 | 878.43 K | $23.03 M | -60.54% | 0.68% |
| NUVEEN, LLC | 08/11/2026 | 834.26 K | $21.87 M | -7.52% | 0.64% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 815.14 K | $21.37 M | 5.62% | 0.63% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 08/14/2026 | 811.75 K | $21.28 M | 61.11% | 0.63% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 663.88 K | $17.41 M | 183.34% | 0.51% |
| FISHMAN JAY A LTD/MI | 07/29/2026 | 595.01 K | $15.60 M | 4.99% | 0.46% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 564.07 K | $14.79 M | 1,043.40% | 0.44% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 547.28 K | $14.35 M | -32.61% | 0.42% |
| SQUAREPOINT OPS LLC | 08/14/2026 | 537.75 K | $14.10 M | -51.27% | 0.42% |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | 08/13/2026 | 500.00 K | $13.11 M | 0.00% | 0.39% |
| NEARWATER CAPITAL MARKETS, LTD | 08/14/2026 | 486.70 K | $12.76 M | -19.86% | 0.38% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 466.00 K | $12.22 M | 27.32% | 0.36% |
| MARSHALL WACE, LLP | 08/13/2026 | 446.87 K | $11.72 M | -81.62% | 0.35% |
| PRIVIUM FUND MANAGEMENT B.V. | 08/07/2026 | 399.37 K | $10.47 M | 24.42% | 0.31% |
| NORGES BANK | 08/12/2026 | 392.30 K | $10.29 M | 100.00% | 0.30% |
| DEUTSCHE BANK AG\ | 08/07/2026 | 382.68 K | $10.03 M | -1.84% | 0.30% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Arcutis Biotherapeutics Inc institutional Ownership - FAQ's
During the previous two years, 351 institutional investors and hedge funds held shares of Arcutis Biotherapeutics Inc. The most heavily invested institutionals were:
SUVRETTA CAPITAL MANAGEMENT, LLC: 12.44 M
BlackRock, Inc.: 10.55 M
Frazier Life Sciences Management, L.P.: 9.87 M
Rubric Capital Management LP: 8.27 M
Polar Capital Holdings Plc: 6.61 M
STATE STREET CORP: 5.82 M
102.32% of Arcutis Biotherapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 153.55 M shares in the last 24 months. This purchase volume represents approximately $3.81 B in transactions.